XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Receipts on Account of Shares [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 3,000 $ 103,107,000 $ 4,000 $ 17,000 $ (101,901,000) $ 1,230,000
Balance, shares at Dec. 31, 2022 3,099,982          
Loss for the period (4,685,000) (4,685,000)
Stock-based compensation 17,000 17,000
Other comprehensive income 260,000   260,000
Deemed dividend resulted from trigger of down round protection feature of certain warrants granted 855,000 (855,000)
Issuance of Common Stock upon private placement transaction (Note 3D) $ 1,000 8,729,000 8,730,000
Issuance of Common Stock upon private placement transaction (Note 3D), shares 1,075,294          
Issuance of restricted shares as compensation towards directors [1] 9,000 (4,000) 5,000
Issuance of shares as compensation to the board of directors, shares 2,998          
Balance at Sep. 30, 2023 $ 4,000 112,960,000 34,000 (107,441,000) 5,557,000
Balance, shares at Sep. 30, 2023 4,178,274          
Balance at Jun. 30, 2023 $ 4,000 112,929,000 28,000 (105,218,000) 7,743,000
Balance, shares at Jun. 30, 2023 4,178,274          
Loss for the period (2,223,000) (2,223,000)
Stock-based compensation 6,000 6,000
Other comprehensive income 31,000 31,000
Balance at Sep. 30, 2023 $ 4,000 112,960,000 34,000 (107,441,000) 5,557,000
Balance, shares at Sep. 30, 2023 4,178,274          
Balance at Dec. 31, 2023 $ 4,000 112,982,000 48,000 16,000 (109,853,000) 3,197,000
Balance, shares at Dec. 31, 2023 4,178,274          
Loss for the period (12,503,000) (12,503,000)
Stock-based compensation (11,000) (11,000)
Other comprehensive income 239,000 239,000
Issuance of Common Stock upon private placement transaction (Note 3D)   500,000 500,000
Issuance of Common Stock upon private placement transaction (Note 3D), shares 79,366          
Issuance of restricted shares as compensation towards directors   126,000 (48,000) 78,000
Issuance of restricted shares as compensation towards directors, shares 86,861          
Restricted shares to be issued as compensation towards directors 100,000 100,000
Exercise of prefunded warrants into shares (Note 3A)  
Exercise of prefunded warrants into shares (Note 3A), shares 395,294          
Exchange of warrants into shares (Note 3B) $ 1,000 (1,000)
Exchange of warrants into shares (Note 3B), shares 718,641          
Issuance of detachable warrants through private placement transactions (Note 3F and Note 3H) 2,635,000 2,635,000
Issuance of shares and warrants as settlement of financial liabilities (Note 3I and Note 3J) $ 1,000 1,742,000 1,743,000
Issuance of Common Stock upon private placement transaction (Note 3D), shares 293,590          
Issuance of restricted shares as payment for a previous achievement of milestone pursuant to purchase agreement (Note 4B)
Issuance of restricted shares as payment for a previous achievement of milestone pursuant to purchase agreement (Note 4B), shares 20,000          
Balance at Sep. 30, 2024 $ 6,000 118,223,000 100,000 5,000 (122,356,000) (4,022,000)
Balance, shares at Sep. 30, 2024 5,772,026          
Balance at Jun. 30, 2024 $ 5,000 113,903,000 50,000 22,000 (117,269,000) (3,289,000)
Balance, shares at Jun. 30, 2024 5,478,436          
Loss for the period (5,087,000) (5,087,000)
Stock-based compensation 11,000 11,000
Other comprehensive income (17,000) (17,000)
Restricted shares to be issued as compensation towards directors 50,000 50,000
Issuance of detachable warrants through private placement transactions (Note 3F and Note 3H) 2,567,000 2,567,000
Settlement of liabilities with equity, shares          
Issuance of shares and warrants as settlement of financial liabilities (Note 3I and Note 3J) 1,000 1,742,000 1,743,000
Balance at Sep. 30, 2024 $ 6,000 $ 118,223,000 $ 100,000 $ 5,000 $ (122,356,000) $ (4,022,000)
Balance, shares at Sep. 30, 2024 5,772,026          
[1] Represents amount lower than $1.